|Articles|April 23, 2021
Improve the Drug Discovery Tool Box
Author(s)PerkinElmer
This whitepaper looks at the requirements for High Throughput Screening, High Content Screening and Surface Plasmon Resonance and makes suggestions for how to make these processes more flexible and repeatable.
Related Content
Trending on PharmExec
1
Novartis Investors Share Concerns Over M&A Strategy: Report
2
The Agentic AI Revolution in Biopharma
3
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
4
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
5